Changing the Future of Cancer Care for the Better
We are pleased to share Miami Cancer Institute’s 2019 Cancer Outcomes Report with you. In a very short time – since opening in 2017 –
we have created an innovative academic-community cancer center with experts who are discovering new ways to prevent, diagnose and
treat cancer. Our patients, whether from South Florida or points far beyond, are always our priority. As we continue to develop sophisticated
treatment plans for our patients, we are dedicated to providing an outstanding patient experience that considers each individual’s needs.
In 2019, we experienced an exciting year of growth and milestones. We added new services and technologies, offered new clinical trials and,
with the expansion of Baptist Health, recently brought the Lynn Cancer Institute at Boca Raton Regional Hospital into our family. We cared for
33,000 patients in 2019, a 12 percent increase since 2018, and saw significant increases in the number of surgeries and procedures as well
as radiation treatments and chemotherapy infusions. In November, we celebrated our 500th patient treated in our Proton Therapy Center, one
of only 28 cancer centers in the United States offering this most technologically advanced method of radiation therapy.
Highlights also included the opening of our Molecular Diagnostics Laboratory, where we perform next-generation sequencing to cover
170 genes commonly associated with solid tumors, and the addition of allogeneic transplants to our Blood and Marrow Transplant program. We
launched our Multidisciplinary Skin Cancer Clinic, the Benign Breast Clinic and our Cardio-Oncology Referral Service (a collaboration with Miami
Cardiac & Vascular Institute). We continue to be recognized in the quality and patient safety arena, achieving accreditations and honors such as
the highest designations of excellence by the American College of Radiology as a Diagnostic Imaging Center of Excellence and a Breast Imaging
Center of Excellence, and the U.S. Oncology Research Site Excellence and the Quality Oncology Practice Initiative.
Our unparalleled compassion and patient services continued to provide support that allowed more patients to conquer and survive cancer.
Through our Cancer Survivorship Clinic we offered a full range of services for children and adults who completed curative treatment, targeted
the management of long-term cancer-related effects, as well as provided programs that promote a healthy lifestyle, from stress management to
Our strategic partnerships also have been important to our success. As an affiliate of Memorial Sloan Kettering, we have adopted the
latest standards of care and increased patient access to clinical trials. We’ve also launched research partnerships with Augusta University,
BocaBiolistics and MT Group, and Florida International University — of which Dr. Zinner serves as their newly appointed Chair of the Herbert
Wertheim College of Medicine’s Department of Surgery, ensuring we train and mentor the next generation of surgeons. Also, we’re active in
the education of physicians and advanced practice providers, offering opportunities for both students and credentialed clinicians to learn from
experts in the field.
Finally, because we genuinely value our community, we offered numerous free education programs and support groups, and sponsored and
participated in many cancer fund-raising events.
Michael J. Zinner, M.D.
Founding CEO and Executive Medical Director
Miami Cancer Institute
Chair of the Herbert Wertheim College of
Medicine’s Department of Surgery
Victor Guardiola, M.D.
Chair, Cancer Committee
Miami Cancer Institute